$AMBQ

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

Original reporting
Published Aug 12, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 3:09 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ambiq (AMBQ) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMBQBullishHigh
01

Why it matters

Traders can update models using the newly stated Q3 revenue range ($36M to $37M) and full-year net sales guidance (about $135M), while stress-testing for shipment delays due to wafer, packaging, substrate, and testing capacity constraints.

02

Market read

Fresh guidance and margin/cash details plus a clear supply-capacity headwind create a tradable setup for near-term estimates and positioning.

03

What to watch

The call notes higher R&D and SG&A tied to IP licensing and public-company costs; if gross margin expansion stalls, operating leverage may be less favorable than implied.

Relevance 9/10Novelty 9/10Timing: pre-market/early trading today after Q2 2026 earnings call

Background

Ambiq’s Q2 2026 earnings call focused on edge-AI demand, product ramp progress (Apollo/Atomiq families), and explicit second-half supply capacity limits.

Company-level read

Ticker impact

$AMBQBullishHigh confidence
Context

Ambiq guided full-year net sales to about $135M and Q3 revenue to $36M to $37M amid edge-AI demand and supply constraints.

Expected impact

Near-term bias likely positive on guidance and gross margin expansion, but tempered by explicit wafer, packaging, and testing capacity headwinds.

Evidence & confidence

The article discloses specific Q2 results, full-year and Q3 revenue ranges, gross margin expansion, and management-identified supply bottlenecks that directly affect near-term revenue realization.

Market effects

Highlights ongoing edge-AI semiconductor supply bottlenecks (wafers, packaging, testing) that can affect peers’ fulfillment and revenue timing.

China exposure rose to 14% of net sales, which may matter for regional demand sensitivity and any export or demand shocks.

Reinforces that AI compute content growth in devices is driving demand for ultra-low-power SoCs, but capacity limits can cap second-half shipments.

Counterpoint

Supply constraints could cause demand to spill into later quarters, making the $135M full-year target optimistic if capacity does not loosen.

Key entities

  • Ambiq Micro, Inc.

    Reported Q2 2026 results and issued Q3 and full-year guidance, citing supply constraints and edge-AI demand acceleration.

  • Fumihide Esaka

    CEO who discussed supply-constrained industry conditions and demand exceeding initial expectations for some products.

  • Jeffrey Winzeler

    CFO who discussed financial results, margin drivers, and cash/expense trends.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$LULUHighAI 9/10

Lululemon sinks after cutting forecast as revenue declines

Lululemon (LULU) shares fell 18% after the company reduced its revenue and profit outlook for 2026. Q2 revenue declined 4% to $2.4B, with comparable sales down 9%. The company now expects full-year revenue of $10.35B-$10.5B, a 5%-7% decrease. Incoming CEO Heidi O'Neill, a Nike veteran, will start next week.

$INODMed

Why Innodata Stock Tumbled by 10% Last Month

Innodata (INOD) reported Q2 revenue of $92.1M, up 58% YoY, and GAAP net income of $14.4M, beating estimates. Despite strong results, its stock fell 10% in August due to a new CEO appointment and a $300M stock offering. The company's reliance on a few key clients is a concern.

$LULUHighAI 8/10

Lululemon makes big cuts to one kind of store

Lululemon (LULU) reported a 4% revenue decline in Q2 2026, with comparable sales down 9%. The company lowered its full-year revenue guidance to $10.35B-$10.5B and earnings to $9.48-$9.73 per share. Lululemon plans to reduce pop-up stores from 65 to 40 by year-end, focusing on permanent locations with proven success. Shares dropped over 17% following the earnings report.